Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Montelukast impurity 12 is a drug impurity associated with Montelukast. This compound is essential for assessing the quality and purity of Montelukast formulations. It is utilized in pharmaceutical research and development, particularly in quality control and regulatory studies to ensure compliance with safety standards. -
Drug Impurity
Dabigatran impurity 9 is a known impurity associated with the anticoagulant drug Dabigatran. This reagent is crucial for analytical and quality control studies, allowing researchers to assess the purity of Dabigatran formulations. Its characterization contributes to the understanding of potential impacts on the drug's efficacy and safety profile in therapeutic applications. -
Drug Impurity
Estradiol benzoate impurity 2 is a chemical impurity associated with Estradiol benzoate. As a minor component, it can serve as an important analytical standard for assessing the purity and quality of Estradiol benzoate samples. This impurity is particularly relevant in pharmaceutical research and quality control settings, where accurate identification and quantification are essential for ensuring drug safety and efficacy. -
Drug Impurity
Candesartan impurity 7 is a chemical impurity associated with Candesartan, an antihypertensive agent targeting the angiotensin II receptor. This intermediate can be used in research to study the synthesis and characterization of drug impurities, contributing to the evaluation of drug quality and safety. Its analysis is crucial for compliance with regulatory standards in pharmaceuticals and for enhancing understanding of drug metabolism and toxicity. -
Drug Impurity
Testosterone Impurity 1 is a chemical impurity associated with the synthesis of Testosterone. This compound may play a role in understanding the pathways and processes involved in steroid hormone production. It is relevant for analytical chemistry applications, particularly in the assessment of pharmaceutical formulations and quality control of Testosterone-containing products. -
Drug Impurity
Azithromycin impurity 16, also known as Azithromycin E, is a specific impurity associated with the antibiotic Azithromycin. This compound is essential for the characterization and quality control of Azithromycin formulations, ensuring the identification of impurities that may affect drug efficacy and safety. Azithromycin impurity 16 is commonly utilized in pharmaceutical research to assess the purity of Azithromycin and to study its related compound profiles. -
Drug Impurity
Sorafenib impurity 3 is a chemical impurity associated with Sorafenib, a multi-kinase inhibitor targeting various receptor tyrosine kinases. This reagent is primarily used in the quality assessment and characterization of Sorafenib formulations, facilitating the understanding of drug metabolites and degradation products. Its analysis is critical for ensuring compliance with regulatory standards in pharmaceutical research and development. -
Drug Impurity
Betamethasone valerate impurity 1 is a known impurity associated with Betamethasone valerate, a corticosteroid used for its anti-inflammatory properties. This compound is relevant for quality control and analytical studies in pharmaceutical research, providing insight into the stability and purity of corticosteroid formulations. It serves as a critical component in ensuring the safety and efficacy of drug products containing Betamethasone valerate. -
Drug Impurity
Desethoxy Quetiapine is a hydroxy impurity of Quetiapine, primarily affecting the assessment of drug purity. This compound is of interest in pharmaceutical research, particularly for understanding the metabolic pathways and degradation products of Quetiapine. Its presence can impact the pharmacological profile and safety evaluation of Quetiapine formulations, facilitating studies on drug stability and quality control. -
Drug Impurity
Cetirizine impurity 11, also known as (S)-Cetirizine, is a drug impurity associated with the antihistamine Cetirizine. This compound serves as an important reference material for analytical and quality control purposes in pharmaceutical research. Its characterization is vital for ensuring the purity and safety of Cetirizine formulations. Researchers can utilize this impurity to study its effects on pharmacodynamics and pharmacokinetics in various biological systems. -
Drug Impurity
Betamethasone valerate impurity 3 is a recognized impurity associated with Betamethasone valerate, a synthetic corticosteroid. This compound is significant for analytics and quality control in pharmaceutical formulations of Betamethasone valerate. Its identification and quantification are critical for ensuring regulatory compliance and the safety of corticosteroid medications. -
Drug Impurity
Ellamod Impurity 11 is a known impurity associated with the pharmaceutical compound Ellamod. It is utilized primarily in analytical and quality control applications to assess the purity and stability of Ellamod formulations. This reagent is crucial for ensuring compliance with regulatory standards in drug development and production. -
Drug Impurity
Brimonidine impurity 1 is a synthetic impurity associated with the pharmacological agent Brimonidine. This compound serves as an important reference standard in the analysis of drug purity and quality control. It is utilized in various research applications, including the assessment of synthesis pathways and the evaluation of impurity profiles in pharmacological studies. -
Drug Impurity
Thioridazine impurity 5 is a characterized impurity related to the antipsychotic agent Thioridazine. This compound is essential for analytical studies, particularly in the assessment of drug purity and quality control processes. Research applications include the identification and quantification of impurities in pharmaceutical formulations. -
Drug Impurity
Itraconazole impurity 17 is a known impurity of Itraconazole, a widely used antifungal agent. This compound is important for the assessment of drug quality and stability in pharmaceutical formulations. Its characterization plays a crucial role in regulatory compliance and ensuring the safety and efficacy of Itraconazole-based treatments. Researchers utilize this impurity for the development of analytical methods and quality control processes in drug production. -
Drug Impurity
Medroxyprogesterone acetate impurity 1 is identified as a drug impurity associated with Medroxyprogesterone acetate. This compound serves as a crucial reference material for assessing the purity and quality of pharmaceutical preparations. Its analysis is essential for ensuring compliance with regulatory standards during the development and quality control of progestin-based therapeutics. -
Drug Impurity
Cetirizine impurity 10 hydrochloride, also known as Cetirizine amide hydrochloride, is a drug impurity associated with Cetirizine hydrochloride. This compound is primarily used in analytical chemistry for the assessment of purity and quality control of Cetirizine formulations. Its presence can be significant in pharmacokinetic studies and the development of regulatory documentation for pharmaceutical products. -
Warfarin Impurity
3-(2-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one is identified as an impurity of Warfarin, a widely used anticoagulant. This compound may be relevant in studies assessing the quality and purity of Warfarin formulations, as well as in research focused on the pharmacokinetics and metabolism of anticoagulants. Its analytical properties can aid in the development and validation of analytical methods in pharmacological research. -
Drug Impurity
Trimetazidine impurity 9, also known as N-Formyl Trimetazidine, is characterized as a drug impurity associated with Trimetazidine. This compound serves as an important reference standard in quality control and analytical studies, aiding in the assessment of drug purity and compliance with regulatory standards. Its identification and quantification are essential for ensuring the safety and efficacy of pharmaceutical formulations. -
Drug Impurity
Apixaban impurity 17 is a characterized impurity related to Apixaban, an anticoagulant that inhibits factor Xa. The presence of this impurity is important for quality control and regulatory compliance in drug formulation. It serves as a reference standard in the analysis and assessment of Apixaban stability and purity, facilitating research and development applications in pharmaceuticals focused on anticoagulant therapies. -
Drug Impurity
Carvedilol impurity 11 is a chemical impurity associated with the drug carvedilol, an antihypertensive agent. This impurity is important for analytical and quality control applications in pharmaceutical research. It aids in the identification and quantification of impurities in formulations to ensure drug safety and efficacy. -
Drug Impurity
Palbociclib impurity 7 is a known impurity of the CDK4/6 inhibitor Palbociclib, which targets the cyclin-dependent kinases involved in cell cycle regulation. This compound is of significant interest for analytical and quality control applications in pharmaceutical research, particularly in the development and refinement of Palbociclib formulations. Its characterization aids in understanding the purity and stability of the primary compound, ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Pantoprazole impurity 3 is a chemical impurity associated with the proton pump inhibitor Pantoprazole. It is primarily used in pharmaceutical research to evaluate drug purity and stability, as well as in the development of analytical methods for quality control. The presence of this impurity can provide insights into the synthesis and degradation pathways of Pantoprazole, aiding in the assessment of its safety and efficacy. -
Drug Impurity
Mebendazole Impurity 2 is a known impurity associated with the anthelmintic agent Mebendazole, primarily arising during its synthesis. This compound can be utilized in the analysis of drug purity and stability studies, serving as a reference for quality control in pharmaceutical formulations. Researchers studying the pharmacokinetics and metabolism of Mebendazole may also find this impurity relevant for understanding potential effects on efficacy and safety profiles. -
Drug Impurity
Progesterone impurity 2 is a known impurity of the hormone progesterone. This compound is primarily used in the analysis and quality control of progesterone formulations. It serves as a critical standard for assessing purity and ensuring the safety and efficacy of progesterone-based drugs in pharmaceutical research. -
Drug Impurity
Rosuvastatin impurity 3 is a known impurity of the cholesterol-lowering agent Rosuvastatin. As a drug impurity, it is essential for use in quality control and analytical testing to ensure the purity and safety of pharmaceutical formulations. This compound serves as a crucial reference standard for the assessment of Rosuvastatin's chemical profile in research and development settings. -
Drug Impurity
Clarithromycin impurity 10 is a known impurity associated with the antibiotic Clarithromycin. This compound serves as a critical reference standard in drug quality control and analytical testing. Its characterization is essential for understanding the impurity profile of drug formulations and ensuring compliance with pharmacopoeial standards. It is primarily utilized in research to assess the safety and efficacy of Clarithromycin and its formulations. -
Drug Impurity
Rosuvastatin N-desmethyl lactone is a known impurity associated with the cholesterol-lowering agent Rosuvastatin. This compound serves as a valuable reference standard for analytical studies related to drug purity and stability testing. Its identification and quantification can help ensure compliance with regulatory standards in the pharmaceutical development process. -
Drug Impurity
Cetirizine impurity 7 is a recognized impurity associated with Cetirizine, an antihistamine widely used in allergy treatment. Its presence is crucial for quality control and analytical studies in pharmaceutical development. This compound aids in the characterization and assessment of Cetirizine formulations, contributing to the overall understanding of drug purity and safety profiles. -
Drug Impurity
Azithromycin impurity 17, also known as Azithromycin 3'-N-oxide, is a drug impurity associated with the antibiotic Azithromycin. It serves as a critical reference standard for quality control and analytical studies, aiding in the assessment of the purity and stability of Azithromycin formulations. Research applications include chromatography analysis and stability studies to evaluate the safety and efficacy of pharmaceutical products containing Azithromycin. -
Drug Impurity
Cinacalcet impurity 11 is a chemical byproduct associated with the synthesis of Cinacalcet, a calcimimetic agent that targets the calcium-sensing receptor. This impurity may be used in quality control and characterization studies to ensure the purity and efficacy of pharmacological formulations. Its identification is crucial for regulatory compliance and for understanding the compound's overall safety profile during preclinical testing. -
Drug Impurity
Sertraline impurity 2 is a chemical byproduct associated with the synthesis of Sertraline, a selective serotonin reuptake inhibitor (SSRI) widely used in the treatment of depression and anxiety disorders. This impurity can serve as a reference standard in quality control and analytical studies, facilitating investigation into the safety and efficacy profiles of Sertraline formulations. Its characterization is essential for ensuring purity and compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Medroxyprogesterone acetate impurity 2 is a known impurity of Medroxyprogesterone acetate, primarily linked to hormone-related drug formulations. It is utilized in research to assess impurity profiles and validate analytical methods in pharmaceutical development. This compound is essential for ensuring the quality and safety of progesterone-based therapies and contributes to understanding the degradation pathways of steroid hormones. -
Drug Impurity
Haloperidol impurity 17 is a chemical impurity associated with the antipsychotic agent Haloperidol. This compound serves as a reference standard for purity assessment and quality control in pharmaceutical formulations. Its characterization is crucial for understanding the safety and efficacy profiles of Haloperidol in clinical applications. Researchers can utilize this impurity in studies related to drug metabolism, stability testing, and compliance with regulatory guidelines. -
Drug Impurity
Bupropion impurity 16 is a chemical impurity associated with the synthesis of Bupropion, a widely used antidepressant and smoking cessation aid. This impurity can be employed in analytical chemistry for the characterization and quality control of pharmaceutical formulations. Its presence and characterization are important for ensuring the purity and efficacy of Bupropion-containing products in research and development settings. -
Drug Impurity
Omeprazole impurity 9 is a specific drug impurity associated with the proton pump inhibitor omeprazole. This compound is crucial for quality control and regulatory compliance in pharmaceutical development. Its analysis may aid in understanding the stability and degradation pathways of omeprazole, supporting research focused on formulation optimization and safety assessments. -
Drug Impurity
Losartan impurity 10, also known as N,O-Ditrityl losartan, is characterized as a drug impurity of Losartan. This compound may be studied for its role in pharmacokinetics, quality control, and the assessment of synthetic processes in drug development. Its presence can help investigate the stability and degradation pathways of Losartan, making it valuable in analytical research and regulatory compliance. -
Drug Impurity
Duloxetine impurity 12 is a chemical byproduct associated with the synthesis of Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI). This impurity serves as an important reference standard for quality control during the development and manufacturing of Duloxetine, ensuring compliance with regulatory requirements. Its analysis contributes to the understanding of potential contaminants and their effects on drug safety and efficacy in pharmacological research. -
Drug Impurity
Aripiprazole impurity 30 is a chemical impurity associated with the antipsychotic drug Aripiprazole. Its presence in formulations is critical for quality control and regulatory compliance in pharmaceutical manufacturing. This impurity can serve as a reference standard for analytical methods, helping to ensure the purity and safety of Aripiprazole-based products in research and development settings. -
Drug Impurity
Levothyroxine Impurity 1 is a synthetic byproduct associated with the synthesis of Levothyroxine. It is primarily utilized in pharmaceutical research for the evaluation of drug quality and stability, as well as in the development of analytical methods for impurity profiling. This reagent aids in the identification and quantification of impurities, ensuring compliance with regulatory standards in drug formulation. -
Netilmicin impurity
1-N-Ethylgaramine sulfate, a known impurity of Netilmicin, acts as a semisynthetic aminoglycoside with broad-spectrum antibiotic properties. Its presence in research and analytical settings is crucial for the study of antibiotic stability, efficacy, and safety profiles. This reagent provides essential insights into the chemical composition and pharmacological characterization of aminoglycoside antibiotics. -
Drug Impurity
Dexmedetomidine impurity 10 is a chemical impurity associated with the sedative agent Dexmedetomidine. This compound may be utilized in pharmacological studies to evaluate the purity and stability of Dexmedetomidine formulations. Its analysis can provide insights into drug quality, safety, and efficacy, contributing to the overall assessment of therapeutic applications and regulatory compliance. -
Drug Impurity
Abacavir Impurity 1 is a known impurity associated with the antiretroviral drug Abacavir. This compound is utilized primarily in analytical chemistry for quality control and validation studies during the manufacturing of Abacavir. Its detection and quantification are crucial for ensuring the purity and safety of pharmaceutical formulations containing Abacavir. -
Drug Impurity
Donepezil impurity 4, known as Donepezil alkene pyridine N-oxide, is a chemical impurity associated with the synthesis of Donepezil. This compound is important for analytical research and quality control in pharmaceutical development, particularly in assessing the purity of Donepezil formulations. Its presence should be monitored during the drug manufacturing process to ensure the integrity and safety of the final product in medicinal applications. -
Drug Impurity
Ciprofloxacin impurity 5 is a byproduct associated with the production of the antibiotic Ciprofloxacin. It may arise during the synthesis or storage of the drug. This impurity is utilized in quality control studies and method validation to ensure the purity of Ciprofloxacin in pharmaceutical formulations. Its monitoring is essential for assessing drug safety and efficacy in compliance with regulatory standards. -
Drug Impurity
Acebutolol impurity 1 is a specific impurity associated with the β-blocker Acebutolol. This compound is primarily used in the evaluation of drug quality and purity in pharmaceutical research. Its analysis aids in the understanding of the stability and degradation pathways of Acebutolol, which is essential for ensuring the safety and efficacy of therapeutic formulations. -
Drug Impurity
Acetazolamide impurity 3 is a significant impurity associated with the drug Acetazolamide, a carbonic anhydrase inhibitor. This compound is important for assessing the purity of pharmaceutical formulations and can provide insights into the synthesis and quality control of Acetazolamide. Research applications include analytical method development and impurity profiling in drug formulation studies. -
Drug Impurity
Ondansetron impurity 1 is a known impurity associated with the antiemetic agent Ondansetron. It serves as a reference material for quality control and stability studies in pharmaceutical development. This compound is essential for assessing the purity of Ondansetron formulations and ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Erlotinib impurity 44 is a synthetic byproduct associated with the drug Erlotinib, which primarily targets the epidermal growth factor receptor (EGFR). This impurity is significant for analytical and quality control applications in pharmaceutical research and development, allowing for the evaluation of drug purity and characterization. Its presence and quantification are crucial for maintaining compliance with regulatory standards in drug formulation and safety assessment studies. -
Drug Impurity
Valenklin impurity 1 is a known impurity of the compound Valenklin. This substance serves as an important reference standard for analytical and quality control applications in pharmaceutical research. Its identification and characterization are crucial for ensuring the purity and compliance of Valenklin in drug formulations.
